Identification of Muscle-Specific Biomarkers of Fatty Acid beta-Oxidation

脂肪酸β-氧化的肌肉特异性生物标志物的鉴定

• 批准号: 8118833
• 负责人: Sean Harrison Adams
• 金额: $ 22.53万
• 依托单位: U.S. AGRICULTURAL RESEARCH SERVICE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-30 至 2013-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8118833
• 关键词: Acetylcarnitine; Acute; Address; Adipose tissue; Aerobic; Aerobic Exercise; Alleles; Animal Model; Attenuated; Automobile Driving; Beds; Biological Markers; Blood Circulation; Blood Glucose; Body fat; Cardiovascular Diseases; Carnitine; Carrier Proteins; Catabolism; Cell Line; Cells; Chemicals; Consensus; Development; Diabetes Mellitus; Diagnostic; Diet; Dietary Intervention; Disease; Dyslipidemias; Etiology; Event; Exercise; Exons; Fasting; Fatty Acids; Fatty acid glycerol esters; Genetic Polymorphism; Glosso-Sterandryl; Health; Health Status; Human; Hypertension; Impaired fasting glycaemia; In Vitro; Individual; Insulin; Insulin Resistance; Intervention; Kidney; Link; Lipids; Liver; Metabolic; Metabolic Diseases; Mitochondria; Modeling; Molecular; Muscle; Muscle Cells; Muscle Fibers; Muscle Mitochondria; Non-Insulin-Dependent Diabetes Mellitus; Nonesterified Fatty Acids; Nutritional; Obesity; Organelles; Overweight; Palmitates; Pancreatic Hormones; Pattern; Peripheral; Persons; Pharmacotherapy; Physical activity; Physiological; Plasma; Predisposition; Preparation; Production; Protocols documentation; Purines; RNA Splicing; Regimen; Research; Risk; Sampling; Signal Transduction; Site; Skeletal Muscle; Specificity; System; Testing; Time; Tissues; Training; Transgenic Animals; Transgenic Mice; Up-Regulation; Work; biological systems; clinically relevant; cohort; design; diabetic; diet and exercise; fatty acid metabolism; fatty acid oxidation; fitness; human subject; improved; insulin sensitivity; insulin signaling; lipid metabolism; metabolomics; mitochondrial uncoupling protein 3; outcome forecast; overexpression; oxidation; premature; prognostic; purine; sedentary; tool; uptake; validation studies

DESCRIPTION (provided by applicant): Elevated fat levels within skeletal muscle cells (intramyocellular lipids) are highly correlated with muscle and whole-body insulin resistance, and more prevalent in obesity. The molecular links and metabolic shifts driving this association remain open to debate, but notably, reduced muscle mitochondrial fatty acid (FA) beta-oxidation is more prevalent among insulin-resistant/diabetic persons. Therefore, discovery of biomarkers reflective of the status of an individual's muscle FA beta-oxidation activity or capacity would have tremendous prognostic and diagnostic value in terms of diabetes. Furthermore, characterization of metabolites associated with muscle mitochondrial fat metabolism should uncover candidate signaling factors which tie FA beta-oxidation to insulin signaling. We propose to identify, for the first time, specific biomarkers of muscle FA beta- oxidation using multiple metabolomic analytical platforms to compare metabolite profiles in samples derived from biological systems displaying disparate muscle fat combustion, including: isolated mitochondrial organelles and muscle cells catabolizing FA at different rates, a UCP3 transgenic animal model, and human subjects harboring a UCP3 truncation polymorphism (Aims 1 & 2). Pilot validation studies in Aim 3 will test whether plasma metabolites and/or metabolite signatures that track muscular FA beta-oxidation (as identified in Aims 1 and 2) can be experimentally increased in obese, insulin-resistant subjects via a diet-exercise regimen designed to improve muscle fitness and FA combustion. Aim 1--Identify Metabolite Biomarkers of Muscle Fat Combustion in Organelle, Cell, and Animal Models Displaying Significantly Altered Fatty Acid beta-Oxidation. We will determine how metabolite profiles shift in models displaying increased muscle beta-oxidation (uncoupling protein 3-overexpressing muscle cell line and muscle UCP3-transgenic mice), and hypothesize that profiles in UCP3-overexpressing systems will reflect increased FA beta-oxidation. Complementary studies will identify tissue-specific metabolites generated by mitochondria in the course of palmitate catabolism in vitro, comparing muscle to liver and kidney preparations. Aim 2--Identify Metabolite Biomarkers of Muscle Fat Combustion in Humans Harboring a UCP3 Missense Polymorphic Allele. We predict that subjects with this polymorphism (which yields a truncated UCP3 and 50% decreased whole-body fat combustion) will display a distinctive plasma metabolite profile indicative of reduced muscle FA oxidation, when compared to subjects without the polymorphism. Aim 3--Determine Whether Metabolomic Profiles Reflective of Muscle Fat Combustion Predict Metabolic Health Changes Following Diet & Exercise Intervention in Obese Subjects. We hypothesize that biomarkers reflective of normal to increased muscle beta-oxidation will be increased, and markers indicative of poor muscle fat combustion reduced, in a cohort of sedentary obese subjects undergoing a 4 month diet- exercise protocol which will increase muscle fitness and improve insulin action. PUBLIC HEALTH RELEVANCE: A reduced ability of the pancreatic hormone insulin to trigger tissue uptake of blood sugar is an early event in the course of development of type 2 diabetes mellitus (T2DM), and the muscle beds are important sites for this phenomenon in many people. Relatively poor fat combustion by fasting muscle is often correlated with insulin resistance, even in the pre-diabetic state. Thus, the overarching aim of our research-- identification of clinically-relevant biomarkers of muscle fat metabolism--is critical to help identify at-risk persons, determine etiology of disease, and ultimately thwart development of T2DM through nutritional, physical activity, and pharmacological interventions.

描述(由申请人提供)：骨骼肌细胞内脂肪水平升高(肌细胞内脂肪)与肌肉和全身胰岛素抵抗高度相关，在肥胖症中更为普遍。推动这种联系的分子联系和代谢变化仍然存在争议，但值得注意的是，肌肉线粒体脂肪酸(FA)β氧化减少在胰岛素抵抗/糖尿病患者中更为普遍。因此，发现反映个体肌肉FAβ-氧化活性或能力状态的生物标志物将对糖尿病具有巨大的预后和诊断价值。此外，与肌肉线粒体脂肪代谢相关的代谢物的特征应该揭示将FAβ氧化与胰岛素信号联系起来的候选信号因子。我们建议首次使用多种代谢组学分析平台来识别肌肉FAβ-氧化的特定生物标志物，以比较来自显示不同肌肉脂肪燃烧的生物系统的样品的代谢物谱，包括：分离的线粒体细胞器和肌肉细胞以不同的速率分解FA，UCP3转基因动物模型，以及具有UCP3截断多态的人类受试者(目标1和2)。AIM 3的试点验证研究将测试跟踪肌肉FAβ-氧化的血浆代谢物和/或代谢物特征(如AIMS 1和2中确定的)是否可以通过旨在改善肌肉健康和FA燃烧的饮食锻炼方案在肥胖、胰岛素抵抗的受试者中实验增加。目的1--鉴定肌肉脂肪燃烧的代谢物生物标志物在器官、细胞和动物模型中表现出显著的脂肪酸β-氧化改变。我们将确定在显示肌肉β氧化增加的模型(解偶联蛋白3过表达的肌肉细胞系和肌肉UCP3转基因小鼠)中代谢物谱如何变化，并假设UCP3过表达系统中的代谢物谱将反映FAβ氧化增加。补充性研究将确定线粒体在体外棕榈酸酯分解代谢过程中产生的组织特异性代谢物，将肌肉与肝脏和肾脏的制剂进行比较。目的2-鉴定携带UCP3错义多态等位基因的人肌肉脂肪燃烧的代谢物生物标记物。我们预测，与没有这种多态的受试者相比，具有这种多态的受试者(产生截短的UCP3和减少50%的全身脂肪燃烧)将显示出独特的血浆代谢物特征，表明肌肉FA氧化减少。目的3--确定反映肌肉脂肪燃烧的代谢谱是否能预测肥胖受试者饮食和运动干预后代谢健康的变化。我们假设，在一组久坐不动的肥胖受试者中，反映肌肉β氧化正常到增加的生物标记物将增加，而指示肌肉脂肪燃烧不良的标记物将减少，这将增加肌肉健康和改善胰岛素作用的4个月饮食锻炼方案。公共卫生相关性：胰腺激素胰岛素触发组织摄取血糖的能力降低是2型糖尿病(T2 DM)发展过程中的早期事件，而肌床是许多人这种现象的重要部位。禁食肌肉导致的相对较差的脂肪燃烧往往与胰岛素抵抗有关，即使在糖尿病前期也是如此。因此，我们研究的首要目标--确定肌肉脂肪代谢的临床相关生物标记物--对于帮助识别高危人群、确定疾病病因，并通过营养、体育活动和药物干预最终阻止T2 DM的发展至关重要。